Palisade Bio Ownership | Who Owns Palisade Bio?
Palisade Bio Ownership Summary
Palisade Bio is owned by 276.14% institutional investors, 0.03% insiders. Franklin resources is the largest institutional shareholder, holding 68.14% of PALI shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.25% of its assets in Palisade Bio shares.
PALI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Palisade Bio | 276.14% | 0.03% | -176.18% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Franklin resources | 5.09M | 68.14% | $11.97M |
| Renaissance | 2.38M | 31.88% | $5.60M |
| Vivo capital | 2.29M | 30.69% | $5.39M |
| Vanguard group | 2.12M | 28.31% | $4.97M |
| Blackrock funding, inc. /de | 1.88M | 25.15% | $4.42M |
| Geode capital management | 1.57M | 20.95% | $3.68M |
| Exome asset management | 758.20K | 10.14% | $1.78M |
| Platinum investment management | 664.09K | 8.89% | $1.56M |
| Hudson bay capital management lp | 656.46K | 8.78% | $1.54M |
| Goldman sachs group | 557.57K | 7.46% | $1.31M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Exome asset management | 758.20K | 0.85% | $1.78M |
| Platinum investment management | 664.09K | 0.36% | $1.56M |
| Vivo capital | 2.29M | 0.35% | $5.39M |
| Caitong asset management | 29.39K | 0.19% | $69.06K |
| Virtus etf advisers | 46.00K | 0.05% | $108.10K |
| Silverarc capital management | 102.11K | 0.03% | $239.95K |
| Bit capital gmbh | 305.00K | 0.03% | $716.75K |
| Total clarity wealth management | 29.93K | 0.02% | $70.35K |
| Pale fire capital se | 70.71K | 0.01% | $166.17K |
| Renaissance | 2.38M | 0.01% | $5.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | 5.09M | 0.00% | 5.09M |
| Renaissance | 2.38M | 0.01% | 2.38M |
| Vivo capital | 2.29M | 0.35% | 2.29M |
| Vanguard group | 2.12M | 0.00% | 2.12M |
| Blackrock funding, inc. /de | 1.88M | 0.00% | 1.88M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Federation des caisses desjardins du quebec | 100.00 | - | - |
| Avion wealth | 500.00 | 0.00% | 500.00 |
| Newbridge financial services group | 15.00K | 0.01% | 2.00K |
| Fny investment advisers | 9.95K | 0.01% | 9.95K |
| Bank of new york mellon | 12.91K | - | 12.91K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Franklin resources | 5.09M | 0.00% | 5.09M | $11.97M |
| Renaissance | 2.38M | 0.01% | 2.38M | $5.60M |
| Vivo capital | 2.29M | 0.35% | 2.29M | $5.39M |
| Vanguard group | 2.12M | 0.00% | 2.12M | $4.97M |
| Blackrock funding, inc. /de | 1.88M | 0.00% | 1.88M | $4.42M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 35 | 191.67% | 20,638,757 | 17157.64% | 276 | 10785.35% | 33 | 266.67% | - | -100.00% |
| Sep 30, 2025 | 12 | 9.09% | 119,592 | 41.34% | 1 | 51.44% | 9 | 80.00% | 1 | -66.67% |
| Jun 30, 2025 | 11 | - | 84,610 | -67.53% | 1 | 5.97% | 5 | -37.50% | 3 | 200.00% |
| Mar 31, 2025 | 11 | 22.22% | 260,593 | 30.80% | 5 | 2.75% | 8 | 33.33% | 1 | - |
| Dec 31, 2024 | 9 | 12.50% | 199,223 | 220.82% | 14 | 73.15% | 6 | 50.00% | 1 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 3.35M | 2.25% | 452.60K |
| Franklin Biotechnology Discovery A | 2.12M | 1.42% | 222.11K |
| Biotech Growth Ord | 1.87M | 1.25% | 1.44M |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.38M | 0.93% | -20.00K |
| Fidelity Extended Market Index | 683.45K | 0.46% | 634.08K |
| Bridgeway Ultra-Small Company | 4.10K | 0.27% | - |
| Blackrock Extended Mkt Fund CF | 376.09K | 0.25% | 376.09K |
| Simplify Propel Opportunities ETF | 350.00K | 0.23% | - |
| Extended Equity Market Fund K | 322.57K | 0.22% | 322.57K |
| JHVIT Total Stock Market Index I | 9.92K | 0.20% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | $3.48K |
| Feb 12, 2026 | Finley John David | CEO, CFO | Sell | $6.82K |
| Jan 16, 2026 | Williams Donald Allen | - | Buy | $8.36K |
| Jan 09, 2026 | Williams Donald Allen | - | Buy | $9.40K |
| May 28, 2024 | Williams Donald Allen | - | Buy | $4.86K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 2 | 2 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
PALI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools